...
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Depression in Choroidal Melanoma Patients Treated with Proton Beam Radiotherapy
【24h】

Depression in Choroidal Melanoma Patients Treated with Proton Beam Radiotherapy

机译:脉络膜黑色瘤患者抑郁症患者用质子梁放射治疗

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Aim: To determine depression in patients with choroidal melanoma (CM) treated with proton beam radiotherapy. Patients and Methods: This was a cross-sectional study including 50 patients with CM (50% males, mean age=49.88 +/- 6.34 years) and 46 age- and sex-matched healthy controls (52% males, mean age=48.60 +/- 8.05 years). Participants completed the Patient Health Questionnaire-9 (PHQ-9) and the Zung Self-Rating Depression Scale (SDS) questionnaires. Results: There was a considerable difference in visual acuity as logarithm of the minimum angle of resolution (logMAR) between the patient and control groups (1.16 +/- 0.97 and 0.04 +/- 0.05 logMAR, respectively, p0.0001). Both PHQ-9 and SDS scores differed significantly between the two groups (10.18 +/- 4.68 and 8.07 +/- 4.90, p=0.04; and 47.94 +/- 12.56 and 39.91 +/- 8.80, p=0.004, respectively). Scores appeared to be positively correlated with logMAR visual acuity (Spearman rho=0.700, p0.0001 for PHQ-9; and 0.767, p0.0001 for SDS), and they were also correlated to each other (Spearman rho=0.759, p0.0001). Conclusion: Patients with CM having undergone proton beam therapy seem to be more depressed compared to a sample of healthy individuals, and the level of depression is correlated with their visual acuity.
机译:目的:确定用质子束放射治疗的脉络膜瘤(CM)患者抑郁症。患者及方法:这是一个横截面研究,包括50例患有50例患者(50%雄性,平均年龄= 49.88 + 6.34岁)和46岁和性爱匹配的健康对照(52%的男性,平均年龄= 48.60 +/- 8.05年)。参与者完成了患者健康问卷-9(PHQ-9)和Zung自评抑郁症(SDS)问卷。结果:视力相当差异,作为患者和对照组分辨率(Logmar)的最小角度的对数(1.16 +/- 0.97和0.04 +/- 0.05 Logmar,P <0.0001)。 PHQ-9和SDS分数都在两组之间显着不同(10.18 +/- 4.68和8.07 +/- 4.90,P = 0.04;和47.94 +/- 12.56和39.91 +/- 8.80,P = 0.004分别)。得分似乎与Logmar视力正相关(Spearman Rho = 0.700,P <0.0001; SDS的0.767,P <0.0001),它们也与彼此相关(Spearman Rho = 0.759,P& 0.0001)。结论:与健康个体样品相比,具有经过质子束治疗的CM的患者似乎更抑制,并且抑郁水平与它们的视力相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号